Novo Nordisk has executed a long-term, full-building lease for a 165,940-rsf property at the Alexandria Center for Life Science in Waltham, Mass. Located at 60 Sylvan Road, the research facility is being redeveloped to provide next-generation environments for biomedical discovery. Neighborhoods of labs, offices, and collaboration spaces will foster interaction between investigators to accelerate the discovery and commercialization of new therapies. Occupancy is expected in 2025.
Work is currently underway to enhance the amenities at the 1.5 million-rsf campus. With a range of outdoor gathering areas, the site will offer flexible conference and meeting venues, a fitness and wellness hub, a vertical farm, and a café.
Based in Pasadena, Calif., Alexandria Real Estate Equities is a leading developer, owner, and operator of innovation centers in North America.
| Organization | Project Role |
|---|---|
|
Alexandria Real Estate Equities
|
Developer
|
